Join
Live feed
·
PRReleasevia Quantisnow
Quoin Pharmaceuticals Ltd. logo

Quoin Pharmaceuticals Provides Clinical and Regulatory Update for QRX009 Topical Rapamycin Development Programs

ByQuantisnow·Wall Street's wire, on your screen.
QNRX· Quoin Pharmaceuticals Ltd.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track QNRX (Quoin Pharmaceuticals Ltd.) and more on Quantisnow.